NYSE: OHI
OMEGA HEALTHCARE INVESTORS INCCIK 0000888491 · Real Estate Investment Trusts
Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.
Sign up freeWant to see a complete report first? Today's free report (FTHM 10-Q) is open in full — no account needed.
Omega Healthcare holds annual meeting; all directors elected, say-on-pay approved at 95%
5 material changes detected. Sign up free to read the summary.
Omega Healthcare announces CEO and CFO departures in planned leadership transition
5 material changes detected. Sign up free to read the summary.
Partner
Trade OHI commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Omega adopts RIDEA operating model, faces $920B Medicaid cuts, extends Genesis DIP loan
5 material changes detected. Sign up free to read the summary.
Omega Healthcare Investors reports Q1 2026 earnings results
1 material change detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Apr 29, 2026 (period ending Mar 31, 2026). SEC XBRL (companyfacts) — not generated by the model.
Consolidated Statements of Operations (Unaudited)
| Description | Q1 ended Mar 31, 2026 | Q1 ended Mar 31, 2025 |
|---|---|---|
| Revenue: | ||
| Total revenue / net sales | 6.7 | |
| Operating expenses: | ||
| General and administrative | 26.0 | 32.1 |
| Total operating expenses | 167.1 | 175.3 |
| Other income/(expense), net | 4.1 | 13.1 |
| Income before income taxes | 159.9 | 114.6 |
| Income tax expense/(benefit) | 5.1 | 3.6 |
| Net income | 151.0 | 109.0 |
| Basic earnings per share | 0.47 | 0.34 |
| Diluted earnings per share | 0.47 | 0.33 |
Consolidated Balance Sheets (Unaudited)
| Description | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and equivalents | 26.1 | 368.0 |
| Finite-lived intangible assets, net | 25.9 | 28.2 |
| Goodwill | 644.4 | 644.1 |
| TOTAL ASSETS | 10,235 | 9,706 |
| Current liabilities: | ||
| Long-term debt | 4,446 | |
| Total liabilities | 4,780 | 4,774 |
| Shareholders' equity: | ||
| Common stock | 29.8 | 28.6 |
| Capital in excess of stated value | 8,775 | 8,180 |
| Accumulated other comprehensive income (loss) | 54.0 | 42.6 |
| Retained earnings (deficit) | 4,828 | 4,196 |
| Total shareholders' equity | 5,191 | 4,741 |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 10,235 | 9,706 |
Consolidated Statements of Cash Flows (Unaudited)
| Description | Q1 ended Mar 31, 2026 | Q1 ended Mar 31, 2025 |
|---|---|---|
| Operating Activities: | ||
| Net cash from operating activities | 215.5 | 182.0 |
| Investing Activities: | ||
| Net cash from investing activities | (270.0) | 19.3 |
| Financing Activities: | ||
| Net cash from financing activities | 54.3 | (347.7) |
| Net increase/(decrease) in cash | (1.2) | (144.7) |
Amounts in millions USD; EPS as reported. Line labels are presentation-friendly mappings of filer XBRL tags — not a re-audit of the full statements. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗